Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/2045894018790905 http://scihub22266oqcxt.onion/10.1177/2045894018790905 C6058424!6058424!29979110     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Pulm+Circ 2018 ; 8 (3): ä Nephropedia Template TP {{tp|p=29979110|t=2018. Levosimendan in pulmonary hypertension and right heart failure |pdf=|usr=}}{{29979110}} gab.com Text Levosimendan in pulmonary hypertension and right heart failure JO: Pulm Circ http://www.kidney.de/pget.php?&tw=1&pmid=29979110 #FOAvip Pulmonary hypertension is a multifactorial disease with a high morbidity and mortality. Right ventricular function is the most important predictor of morbidity and mortality in patients suffering from pulmonary hypertension, but currently there are no approved treatments directly supporting the failing right ventricle. Levosimendan is a calcium sensitizing agent with inotropic, pulmonary vasodilatory, and cardioprotective properties. Given its pharmacodynamic profile, levosimendan could be a potential novel agent for the treatment of right ventricular failure caused by pulmonary hypertension. The aim of this review is to provide an overview of the current knowledge on the effects of levosimendan in pulmonary hypertension and right heart failure. Twit Text FOAVip Levosimendan in pulmonary hypertension and right heart failure ????Pulm Circ http://www.kidney.de/pget.php?&tw=1&pmid=29979110 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29979110 #FOAvip English Wikipedia <ref>{{Cite pmid|29979110}}</ref> Levosimendan in pulmonary hypertension and right heart failure #MMPMID29979110 Hansen MS; Andersen A; Nielsen-Kudsk JE Pulm Circ 2018[Jul]; 8 (3): ä PMID29979110show ga Pulmonary hypertension is a multifactorial disease with a high morbidity and mortality. Right ventricular function is the most important predictor of morbidity and mortality in patients suffering from pulmonary hypertension, but currently there are no approved treatments directly supporting the failing right ventricle. Levosimendan is a calcium sensitizing agent with inotropic, pulmonary vasodilatory, and cardioprotective properties. Given its pharmacodynamic profile, levosimendan could be a potential novel agent for the treatment of right ventricular failure caused by pulmonary hypertension. The aim of this review is to provide an overview of the current knowledge on the effects of levosimendan in pulmonary hypertension and right heart failure. äLevosimendan in pulmonary hypertension and right heart failure (epmc).pdf DeepDyve Pubget Overpricing